$2.02 Billion is the total value of Saratoga Research & Investment Management's 47 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BMY | Bristol-Myers Squibb | $302,000 | +5.6% | 3,919 | 0.0% | 0.02% | +25.0% | |
| PFE | Pfizer | $305,000 | +1.3% | 5,821 | 0.0% | 0.02% | +15.4% | |
| MMP | Magellan Midstream Partners LPetp | $215,000 | -2.7% | 4,500 | 0.0% | 0.01% | +10.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-01
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICROSOFT CORP | 42 | Q3 2023 | 7.3% |
| Oracle | 42 | Q3 2023 | 6.7% |
| Novo Nordisk ADR | 42 | Q3 2023 | 6.3% |
| Cisco Systems | 42 | Q3 2023 | 5.8% |
| C.H. Robinson Worldwide | 42 | Q3 2023 | 5.7% |
| WAL-MART STORES INC | 42 | Q3 2023 | 6.2% |
| Procter & Gamble | 42 | Q3 2023 | 4.4% |
| NIKE | 42 | Q3 2023 | 4.6% |
| JOHNSON & JOHNSON | 42 | Q3 2023 | 4.1% |
| Cognizant Tech Solutions | 42 | Q3 2023 | 4.7% |
View Saratoga Research & Investment Management's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-17 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-07-24 |
| 13F-HR | 2023-05-05 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-10-31 |
| 13F-HR | 2022-08-01 |
| 13F-HR | 2022-04-29 |
| 13F-HR | 2022-02-08 |
View Saratoga Research & Investment Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.